Dual leucine-zipper kinase (DLK) drives several forms of neurodegeneration but inhibitors of DLK’s kinase domain cause adverse effects. Zhang et al describe an alternative strategy to block DLK signaling by targeting the axonal palmitoylation of DLK.
- Xiaotian Zhang
- Heykyeong Jeong
- Gareth M. Thomas
